Insider Trading

MDCX Stock  USD 2.81  0.14  5.24%   
Slightly above 55% of Medicus Pharma's investors are presently thinking to get in. The analysis of overall sentiment of trading Medicus Pharma Ltd otc bb equity suggests that some investors are interested at this time. Medicus Pharma's investing sentiment can be driven by a variety of factors including economic data, Medicus Pharma's earnings reports, geopolitical events, and overall market trends.
  
Filed transaction by Medicus Pharma Ltd Director. Insider Public Trading

Read at macroaxis.com
General Transaction of 25000 stock option (right to buy) at 0.81 of Medicus Pharma by Ashton William on 31st of December 2024. This event was filed by Medicus Pharma Ltd with SEC on 2024-12-31. Initial filing of beneficial ownership - SEC Form 3

Cash Flow Correlation

Medicus Pharma's cash-flow correlation analysis can be used to evaluate the unsystematic risk during the given period. It also helps investors identify the Medicus Pharma's relationships between the major components of the statement of changes in financial position and other commonly used cash-related accounts. When such correlations are discovered, they may help managers and analysts to enhance performance or determine appealing investment opportunities.
Click cells to compare fundamentals

Medicus Pharma Fundamental Analysis

We analyze Medicus Pharma's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Medicus Pharma using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Medicus Pharma based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Working Capital

Working Capital Comparative Analysis

Medicus Pharma is currently under evaluation in working capital category among its peers. Working Capital is a measure of company efficiency and operating liquidity. The working capital is usually calculated by subtracting Current Liabilities from Current Assets. It is an important indicator of the firm ability to continue its normal operations without additional debt obligations. .

Medicus Pharma Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Medicus Pharma otc bb equity to make a market-neutral strategy. Peer analysis of Medicus Pharma could also be used in its relative valuation, which is a method of valuing Medicus Pharma by comparing valuation metrics with similar companies.

Additional Tools for Medicus OTC BB Equity Analysis

When running Medicus Pharma's price analysis, check to measure Medicus Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medicus Pharma is operating at the current time. Most of Medicus Pharma's value examination focuses on studying past and present price action to predict the probability of Medicus Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medicus Pharma's price. Additionally, you may evaluate how the addition of Medicus Pharma to your portfolios can decrease your overall portfolio volatility.